COVID-19 Impact on GE Healthcare LLC’s Revenue and Operations (Medical Devices)
GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a provider of transformational medical technologies and services, and professional consulting services. It operates in more than 100 countries worldwide. GE Healthcare is headquartered in Chicago, Illinois, the US. GE Healthcare develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cellular technologies; imaging agents used during medical scanning procedures; and a range of healthcare IT solutions. GE Healthcare also provides services such as performance improvement and performance solutions services, computerized data management and remote diagnostic and repair services of medical equipment. The report, COVID-19 Impact on GE Healthcare LLC’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how GE Healthcare LLC is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Deep dive analysis into how GE Healthcare LLC is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
- Sales have significantly declined in heavily impacted regions, particularly US and Europe that has seen a rapid rise of COVID-19 cases.
- Inspite of the impact across most segments, a global demand for critical care equipment, ventilators, and some diagnostic equipment have been constantly increasing since the outbreak; the company could see increased sales in these segments.
The report provides a comprehensive analysis of the impact of COVID-19 on GE Healthcare LLC -
- It provides insights on GE Healthcare LLC’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Reasons To Buy
- An overview of how GE Healthcare LLC will be affected by the COVID-19 pandemic.